Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Indo Livestock ExpoIndo Livestock Expo
Not Confirmed
Not Confirmed
02-04 July, 2025
Not Confirmed
Not Confirmed
04-07 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Indo Livestock ExpoIndo Livestock Expo
Industry Trade Show
Not Confirmed
02-04 July, 2025
Industry Trade Show
Not Confirmed
04-07 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
14 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-bimzelx-bimekizumab-bkzx-data-at-acr-convergence-2024-highlights-ucbs-efforts-to-deliver-differentiated-care-for-patients-with-psoriatic-arthritis-and-axial-spondyloarthritis-302306120.html
13 Nov 2024
// EXPRESSPHARMA
https://www.expresspharma.in/ucb-and-biogens-dapirolizumab-pegol-paves-path-for-systemic-lupus-erythematosus-treatment-2/
01 Nov 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/ucbs-tau-drug-flunks-phase-2-alzheimers-trial-days-after-roches-exit-120m-bet
07 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/the-positive-topline-results-from-phase-iii-study-of-ucbbiogens-dapirolizumab-pegol-brings-a-ray-of-hope-in-systemic-lupus-erythematosus-therapeutic-space--delveinsight-302268558.html
27 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ucb-announces-late-breaking-two-year-data-for-bimzelx-bimekizumab-bkzx-in-moderate-to-severe-hidradenitis-suppurativa-at-eadv-2024-302260703.html
25 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ucb-presents-new-4-year-data-for-bimzelx-bimekizumab-bkzx-in-moderate-to-severe-plaque-psoriasis-at-eadv-2024-302257850.html
Inspections and registrations
ABOUT THIS PAGE
UCB Farchim SA is a supplier offers 4 products (APIs, Excipients or Intermediates).
Find a price of Brivaracetam bulk offered by UCB Farchim SA
Find a price of Cetirizine Dihydrochloride bulk offered by UCB Farchim SA
Find a price of Levetiracetam bulk offered by UCB Farchim SA
Find a price of Levocetirizine Dihydrochloride bulk offered by UCB Farchim SA